Symbols

HCAT

Health Catalyst·NASDAQ

--(--)

HCAT fundamentals

HCAT Q4 2025 Earnings

Health Catalyst (HCAT) released its earnings on Mar 12, 2026: revenue was 74.68M (YoY -6.19%), beat estimates; EPS was 0.08 (YoY +100.00%), missed estimates.

Revenue / YoY

74.68M

-6.19%

EPS / YoY

0.08

+100.00%

Report date

Mar 12, 2026

HCAT Earnings Call Summary for Q4,2025

Leadership Shift: New CEO prioritizes operational efficiency, AI investment, and simplifying the business model.
Financial Performance: 2025 revenue growth of 1%, EBITDA up 59%, but Q1 2026 guidance reflects migration-related declines.
Migration Risks: $52 million ARR at risk from DOS to Ignite, with 75% impact expected in 2026.
Growth Drivers: AI, India expansion, and focus on cost/clinical quality solutions offset near-term margin pressure.
Application Resilience: 93% retention rate, with applications retained even as data platforms downsell.

Earnings

EPS

Revenue

Revenue & Expenses

HCAT has released its 2025 Q4 earnings report, with revenue of 74.68M, reflecting a YoY change of -6.19%, and net profit of -91.03M, showing a YoY change of -340.31%. The Sankey diagram below clearly presents HCAT's revenue sources and cost distribution.

Key Indicators

Health Catalyst (HCAT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Health Catalyst (HCAT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Health Catalyst (HCAT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Health Catalyst (HCAT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown